Nicotinic Acetylcholine Receptor beta (CHRNB1) (Middle Region) Peptid
CHRNB1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle CHRNB1 Produkte
- CHRNB1 (Nicotinic Acetylcholine Receptor beta (CHRNB1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- GLILAQLISL NEKDEEMSTK VYLDLEWTDY RLSWDPAEHD GIDSLRITAE
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti- CHRNB1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CHRNB1 (Nicotinic Acetylcholine Receptor beta (CHRNB1))
- Hintergrund
-
The muscle acetylcholine receptor is composed of five subunits: two alpha subunits and one beta, one gamma, and one delta subunit. This gene encodes the beta subunit of the acetylcholine receptor. The acetylcholine receptor changes conformation upon acetylcholine binding leading to the opening of an ion-conducting channel across the plasma membrane. Mutations in this gene are associated with slow-channel congenital myasthenic syndrome.
Alias Symbols: ACHRB, CHRNB, CMS1D, CMS2A, CMS2C, SCCMS
Protein Size: 501 - Gen-ID
- 1140
- NCBI Accession
- NM_000747, NP_000738
- UniProt
- P11230
-
Sie sind hier:
